Journal
CURRENT PHARMACEUTICAL BIOTECHNOLOGY
Volume 20, Issue 13, Pages 1108-1121Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1389201020666190809112704
Keywords
Immunotherapy; monoclonal antibodies; viral diseases; treatment; emerging viruses; immunotherapeutics
Ask authors/readers for more resources
The epidemiological impact of viral diseases, combined with the emergence and re-emergence of some viruses, and the difficulties in identifying effective therapies, have encouraged several studies to develop new therapeutic strategies for viral infections. In this context, the use of immunotherapy for the treatment of viral diseases is increasing. One of the strategies of immunotherapy is the use of antibodies, particularly the monoclonal antibodies (mAbs) and multi-specific antibodies, which bind directly to the viral antigen and bring about activation of the immune system. With current advancements in science and technology, several such antibodies are being tested, and some are already approved and are undergoing clinical trials. The present work aims to review the status of mAb development for the treatment of viral diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available